A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)

NCT06616974 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Hypertension
Heart Failure With Preserved Ejection Fraction

Interventions

DRUG: TX000045- Dose A
DRUG: TX000045- Dose B
DRUG: Placebo

Sponsor

Tectonic Therapeutic